Clinical trial
Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat…
NCT00054613 · Mallinckrodt, Industry · Completed
Key facts
| NCT number | NCT00054613 |
|---|---|
| Title | Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease |
| Official title | A Randomized Single-Blind Study of Extracorporeal Photoimmune Therapy With UVADEX in Conjunction With Standard Therapy Alone for the Treatment of Patients With Corticosteroid-Refractory, Corticosteroid-Dependent, or Corticosteroid-Intolerant Chronic Graft-versus-Host Disease |
| Lead sponsor | Mallinckrodt, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Graft-versus-Host Disease |
| Intervention type | Drug, Procedure |
| Interventions | Methoxsalen, Extracorporeal Photopheresis |
| Enrollment | 72 |
| Start date | Jun 1, 2002 |
| Completion | Mar 1, 2004 |
| First posted | Feb 6, 2003 |
| Last update posted | Aug 16, 2017 |
| Countries | Australia, Austria, France, Germany, Italy, Portugal, Slovakia, Spain, Switzerland, Turkey (Türkiye), United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: